This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Campbell, P. M. Articles by Der, C. J. Search for Related Content PubMed PubMed Citation Articles by Campbell, P. M. Articles by Der, C. J.

K-Ras Promotes Growth Transformation and Invasion of Immortalized Human Pancreatic Cells by Raf and Phosphatidylinositol 3-Kinase Signaling

¹ Lineberger Comprehensive Cancer Center and Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; ² Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska; and ³ NexusPharma, Inc., Langhorne, Pennsylvania

Requests for reprints: Channing J. Der, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, CB# 7295, Chapel Hill, NC 27599-7295. Phone: 919-966-5634; Fax: 919-966-0162; E-mail: cjder{at}med.unc.edu.

Mutational activation of the K-Ras oncogene is well established as a key genetic step in the development and growth of pancreatic adenocarcinomas. However, the mechanism by which aberrant Ras signaling promotes uncontrolled pancreatic tumor cell growth remains to be fully elucidated. The recent use of primary human cells to study Ras-mediated oncogenesis provides important model cell systems to dissect this mechanism. We have used a model of telomerase-immortalized human pancreatic duct-derived cells (E6/E7/st) to study mechanisms of Ras growth transformation. First, we found that human papillomavirus E6 and E7 oncogenes, which block the function of the p53 and Rb tumor suppressors, respectively, and SV40 small t antigen were required to allow mutant K-Ras(12D) growth transformation. Second, K-Ras(12D) caused growth transformation in vitro, including enhanced growth rate and loss of density dependency for growth, anchorage independence, and invasion through reconstituted basement membrane proteins, and tumorigenic transformation in vivo. Third, we determined that the Raf, phosphatidylinositol 3-kinase (PI3K), and Ral guanine nucleotide exchange factor effector pathways were activated, although extracellular signal-regulated kinase (ERK) activity was not up-regulated persistently. Finally, pharmacologic inhibition of Raf/mitogen-activated protein kinase/ERK and PI3K signaling impaired K-Ras–induced anchorage-independent growth and invasion. In summary, our studies established, characterized, and validated E6/E7/st cells for the study of Ras-induced oncogenesis. [Cancer Res 2007;67(5):2098–106]

This article has been cited by other articles:

				H. Laklai, S. Laval, L. Dumartin, P. Rochaix, M. Hagedorn, A. Bikfalvi, S. Le Guellec, M.-B. Delisle, A. V. Schally, C. Susini, et al. Thrombospondin-1 is a critical effector of oncosuppressive activity of sst2 somatostatin receptor on pancreatic cancer PNAS, October 20, 2009; 106(42): 17769 - 17774. [Abstract] [Full Text] [PDF]

				Y. Matsuo, P. M. Campbell, R. A. Brekken, B. Sung, M. M. Ouellette, J. B. Fleming, B. B. Aggarwal, C. J. Der, and S. Guha K-Ras Promotes Angiogenesis Mediated by Immortalized Human Pancreatic Epithelial Cells through Mitogen-Activated Protein Kinase Signaling Pathways Mol. Cancer Res., June 1, 2009; 7(6): 799 - 808. [Abstract] [Full Text] [PDF]

				N. T. Ihle, R. Lemos Jr., P. Wipf, A. Yacoub, C. Mitchell, D. Siwak, G. B. Mills, P. Dent, D. L. Kirkpatrick, and G. Powis Mutations in the Phosphatidylinositol-3-Kinase Pathway Predict for Antitumor Activity of the Inhibitor PX-866 whereas Oncogenic Ras Is a Dominant Predictor for Resistance Cancer Res., January 1, 2009; 69(1): 143 - 150. [Abstract] [Full Text] [PDF]

				F. Di Nicolantonio, S. Arena, M. Gallicchio, D. Zecchin, M. Martini, S. E. Flonta, G. M. Stella, S. Lamba, C. Cancelliere, M. Russo, et al. Replacement of normal with mutant alleles in the genome of normal human cells unveils mutation-specific drug responses PNAS, December 30, 2008; 105(52): 20864 - 20869. [Abstract] [Full Text] [PDF]

				S. A. Lang, P. Schachtschneider, C. Moser, A. Mori, C. Hackl, A. Gaumann, D. Batt, H. J. Schlitt, E. K. Geissler, and O. Stoeltzing Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytes Mol. Cancer Ther., November 1, 2008; 7(11): 3509 - 3518. [Abstract] [Full Text] [PDF]

				K. Oda, J. Okada, L. Timmerman, P. Rodriguez-Viciana, D. Stokoe, K. Shoji, Y. Taketani, H. Kuramoto, Z. A. Knight, K. M. Shokat, et al. PIK3CA Cooperates with Other Phosphatidylinositol 3'-Kinase Pathway Mutations to Effect Oncogenic Transformation Cancer Res., October 1, 2008; 68(19): 8127 - 8136. [Abstract] [Full Text] [PDF]

				J. M. Bailey, B. J. Swanson, T. Hamada, J. P. Eggers, P. K. Singh, T. Caffery, M. M. Ouellette, and M. A. Hollingsworth Sonic Hedgehog Promotes Desmoplasia in Pancreatic Cancer Clin. Cancer Res., October 1, 2008; 14(19): 5995 - 6004. [Abstract] [Full Text] [PDF]

				I. Macias-Perez, C. Borza, X. Chen, X. Yan, R. Ibanez, G. Mernaugh, L. M. Matrisian, R. Zent, and A. Pozzi Loss of Integrin {alpha}1{beta}1 Ameliorates Kras-Induced Lung Cancer Cancer Res., August 1, 2008; 68(15): 6127 - 6135. [Abstract] [Full Text] [PDF]

				G.-M. Zou and A. Maitra Small-molecule inhibitor of the AP endonuclease 1/REF-1 E3330 inhibits pancreatic cancer cell growth and migration Mol. Cancer Ther., July 1, 2008; 7(7): 2012 - 2021. [Abstract] [Full Text] [PDF]

				H.-Y. Fan, M. Shimada, Z. Liu, N. Cahill, N. Noma, Y. Wu, J. Gossen, and J. S. Richards Selective expression of KrasG12D in granulosa cells of the mouse ovary causes defects in follicle development and ovulation Development, June 15, 2008; 135(12): 2127 - 2137. [Abstract] [Full Text] [PDF]

				H. Hao, V. M. Muniz-Medina, H. Mehta, N. E. Thomas, V. Khazak, C. J. Der, and J. M. Shields Context-dependent roles of mutant B-Raf signaling in melanoma and colorectal carcinoma cell growth Mol. Cancer Ther., August 1, 2007; 6(8): 2220 - 2229. [Abstract] [Full Text] [PDF]